NZM2:ETR
Novozymes
51,12 €
0,00%
(0,00) 1D
29. apr., 17:35:37 GMT +2 · EUR
search
Vsi simboli
1D
5D
1M
6M
TLDD
1L
5L
MAKS
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za NZM2 …
Tržna kapitalizacija
165,66 mrd.
Povprečni promet
179,00
Promet
0,00
52-tedenski najvišji tečaj
57,24 €
52-tedenski najnižji tečaj
46,74 €
Št. zaposlenih
11 tis.
Novice
Iz virov v spletu
Simply Wall Street
·
pred 23 minutami
Coinbase Expands Stablecoin Credit And Payments Role As Valuation Questions Linger
Simply Wall Street
·
pred 23 minutami
Summit Therapeutics (SMMT) Is Down 27.0% After HARMONi-6 OS Plenary, BLA Progress And Wider Losses - Has The Bull Case Changed?
Simply Wall Street
·
pred 23 minutami
Palantir Maven Win Raises Questions On Valuation And Defense Revenue Visibility
Investor's Business Daily
·
pred 2 urama
Dow Jones Futures: Stock Market Hits High After Bullish Pause; Apple, Broadcom In Buy Zones
Profil
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
Vizitka: Novozymes
Generalni direktorEster Baiget
Št. zaposlenih11,1 tis.
Ustanovljeno2000
Sedež-
SektorSpeciality chemicals
Spletno mestonovonesis.com
Vsebina z UI lahko vsebuje napake. Več o tem